Neurofibromatosis in children: the role of the orthopaedist.
about
Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: a case study in measurement selectionBilateral and symmetrical anteromedial bowing of the lower limbs in a patient with neurofibromatosis type-I.Tibial geometry in individuals with neurofibromatosis type 1 without anterolateral bowing of the lower leg using peripheral quantitative computed tomography.Double inactivation of NF1 in tibial pseudarthrosis.Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation.Valosin-containing protein and neurofibromin interact to regulate dendritic spine densityEvidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysisThe use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1.Bone resorption in syndromes of the Ras/MAPK pathway.Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1Bone mineral density in children and adolescents with neurofibromatosis type 1.Vitamin D Status and VDR Genotype in NF1 Patients: A Case-Control Study from Southern Brazil.Epidemiology and treatment outcome of congenital pseudarthrosis of the tibiaSurgical Treatment of Dystrophic Spinal Curves Caused by Neurofibromatosis Type 1: A Retrospective Study of 26 Patients.Posterior-only spinal fusion without rib head resection for treating type I neurofibromatosis with intra-canal rib head dislocation.Analysis of radiographic characteristics of anterolateral bowing of the leg before fracture in neurofibromatosis type 1.Not just a fracture.Congenital pseudarthrosis of the tibia: the results of an evolving protocol of management.Health-related quality of life measures in genetic disorders: an outcome variable for consideration in clinical trials
P2860
Q24800678-0007A5EB-00DA-4482-B41C-9CEAAACEBBB4Q30415933-287B0078-5EA1-4CED-A1B4-3FCC799F2685Q33396860-1891D39D-1083-4CC9-B90D-7E96C958395FQ34658446-45FB0996-6B0A-4F83-AFAB-7B7C61494AE7Q35157847-CD7CF8B5-44D1-40DB-9DF3-AFA998521551Q35225250-EA1CC499-5FF8-41A3-B3A0-A59A2A67B7AAQ35253119-3CDBD068-8A1E-42C2-BDFE-0E486AA80350Q35578562-170F0953-A483-4DDC-A529-E1570936D951Q35605316-9653D8D7-5DC5-4746-AFEA-B5064B1AC5DDQ35627964-151AB8E3-5918-4B91-8511-E36D3941310BQ35635487-1BF55BD1-CC11-4297-BD5C-3C858D57DB1CQ35635492-B4C2351F-A27C-43AB-85F8-60930E647DF1Q35659149-4FFC9F01-35B3-4071-9829-35FCF31C7009Q35804575-9A016CE1-7D93-4A25-85C9-8738B92AF3A3Q36670369-EC17F20A-F369-4E2F-A428-CAFE1BDFA99FQ37206803-882F94CA-FD6B-43E7-8C01-B38370BCC9E0Q37342524-779C1D62-6297-4C98-9D77-CF90F317AE06Q37349711-9E3AE47A-3EDE-4D7A-B554-C5C0624F42EFQ37570663-A3648BE1-9A77-4EA9-8A57-450407927B63Q41935583-620B657B-AAF7-41C1-A509-E3A85B475D02Q42042781-E0C78F9E-4BE2-4963-AB79-AD9EEA46E43A
P2860
Neurofibromatosis in children: the role of the orthopaedist.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Neurofibromatosis in children: the role of the orthopaedist.
@ast
Neurofibromatosis in children: the role of the orthopaedist.
@en
type
label
Neurofibromatosis in children: the role of the orthopaedist.
@ast
Neurofibromatosis in children: the role of the orthopaedist.
@en
prefLabel
Neurofibromatosis in children: the role of the orthopaedist.
@ast
Neurofibromatosis in children: the role of the orthopaedist.
@en
P1476
Neurofibromatosis in children: the role of the orthopaedist
@en
P2093
A H Crawford
E K Schorry
P304
P356
10.5435/00124635-199907000-00002
P577
1999-07-01T00:00:00Z